Detalhe da pesquisa
1.
The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation.
Drug Resist Updat
; 43: 29-37, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054489
2.
WINDOW consortium: A path towards increased therapy efficacy against glioblastoma.
Drug Resist Updat
; 40: 17-24, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30439622
3.
Explaining Blood-Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms.
J Med Chem
; 66(11): 7253-7267, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217193
4.
Practice variation in the conservative and surgical treatment of chronic subdural hematoma.
Clin Neurol Neurosurg
; 195: 105899, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516640
5.
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
Nat Commun
; 11(1): 2935, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32523045
6.
Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
Mol Cancer Ther
; 17(2): 347-354, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958992